|
|
|
Weekly News Digest
 |
August 26, 2002 — In addition to this week's NewsBreaks article and the monthly NewsLink Spotlight, Information Today, Inc. (ITI) offers Weekly News Digests that feature recent product news and company announcements. Watch for additional coverage to appear in the next print issue of Information Today. For other up-to-the-minute news, check out ITI’s Twitter account: @ITINewsBreaks.
CLICK HERE to view more Weekly News Digest items.
|
Thomson Acquires Current Drugs, Ltd.
Thomson Corp. has announced that it has acquired privately held Current Drugs, Ltd. (http://www.current-drugs.com), a U.K.-based provider of integrated competitor intelligence services. Current Drugs features databases, systems, and services such as the Investigational Drugs database (IDdb), a resource for scientists and business executives who are involved in drug research and development. Financial terms of the agreement were not disclosed.Current Drugs' IDdb delivers content in a manner that enables integration with a client's own proprietary data and supports the researcher work flow by using a proprietary thesaurus. In addition to IDdb, Current Drugs provides products that focus on specific areas of scientific research, including the review journal Current Opinion in Drug Discovery and Development and patent-based competitor intelligence services for the bio-pharmaceutical sector. Current Drugs will become a part of Thomson's Scientific & Healthcare operating group. It will continue to be run by its current business-management group, which is led by Ian Tarr. Source: Thomson Corp.
Send correspondence concerning the Weekly News Digest to NewsBreaks Editor
Brandi Scardilli
|
